VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 42 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,478 | -30.2% | 10,419 | +3.7% | 0.00% | – |
| Q2 2023 | $57,977 | +9.4% | 10,048 | +54.5% | 0.00% | – |
| Q1 2022 | $53,000 | -17.2% | 6,502 | -6.6% | 0.00% | – |
| Q4 2021 | $64,000 | -28.9% | 6,960 | -2.9% | 0.00% | – |
| Q3 2021 | $90,000 | +8.4% | 7,168 | -2.3% | 0.00% | – |
| Q2 2021 | $83,000 | -24.5% | 7,339 | +1.2% | 0.00% | – |
| Q1 2021 | $110,000 | +32.5% | 7,250 | +0.3% | 0.00% | – |
| Q4 2020 | $83,000 | +43.1% | 7,231 | -2.8% | 0.00% | – |
| Q3 2020 | $58,000 | -31.0% | 7,439 | -2.2% | 0.00% | – |
| Q2 2020 | $84,000 | +1.2% | 7,608 | -0.3% | 0.00% | – |
| Q1 2020 | $83,000 | -35.2% | 7,632 | -5.5% | 0.00% | – |
| Q4 2019 | $128,000 | +6.7% | 8,073 | -0.8% | 0.00% | – |
| Q3 2019 | $120,000 | +26.3% | 8,140 | -0.7% | 0.00% | – |
| Q2 2019 | $95,000 | +28.4% | 8,198 | +19.5% | 0.00% | – |
| Q1 2019 | $74,000 | +138.7% | 6,861 | +79.6% | 0.00% | – |
| Q4 2018 | $31,000 | -50.8% | 3,821 | -0.8% | 0.00% | – |
| Q3 2018 | $63,000 | – | 3,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 562,954 | $8,529,000 | 2.37% |
| Perceptive Advisors | 3,610,412 | $54,698,000 | 0.69% |
| KNOTT DAVID M | 78,424 | $1,188,000 | 0.51% |
| Monashee Investment Management LLC | 200,000 | $3,030,000 | 0.47% |
| Fosun International Ltd | 282,408 | $4,279,000 | 0.34% |
| Parian Global Management LP | 39,560 | $599,000 | 0.27% |
| Orbimed Advisors | 1,479,733 | $22,418,000 | 0.21% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 719,836 | $10,906,000 | 0.18% |
| SteelPeak Wealth, LLC | 132,961 | $2,014,000 | 0.16% |
| Pinz Capital Management, LP | 13,422 | $203,000 | 0.05% |